Vertex Pharmaceuticals, Inc’s filing revealed that its Director Bhatia Sangeeta N. unloaded Company’s shares for reported $0.1 million on Aug 27 ’25. In the deal valued at $386.69 per share,266 shares were sold. As a result of this transaction, Bhatia Sangeeta N. now holds 4,565 shares worth roughly $1.81 million.
Then, Bhatia Sangeeta N. bought 266 shares, generating $102,860 in total proceeds.
Before that, Kewalramani Reshma bought 10,000 shares. Vertex Pharmaceuticals, Inc shares valued at $3,895,768 were divested by the CEO & President at a price of $389.58 per share. As a result of the transaction, Kewalramani Reshma now holds 115,968 shares, worth roughly $45.98 million.
Raymond James initiated its Vertex Pharmaceuticals, Inc [VRTX] rating to a Mkt perform in a research note published recently. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in early August from “an Equal weight” to “an Overweight”. Wolfe Research also remained covering VRTX and has decreased its forecast on May 07, 2025 with a “Peer perform” recommendation from previously “an Outperform” rating. Leerink Partners revised its rating on May 06, 2025. It rated VRTX as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of VRTX
On Tuesday, Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] saw its stock jump 0.31% to $396.48. Over the last five days, the stock has lost -1.13%. Vertex Pharmaceuticals, Inc shares have fallen nearly -15.39% since the year began. Nevertheless, the stocks have fallen -1.54% over the past one year. While a 52-week high of $519.88 was reached on 03/14/25, a 52-week low of $362.50 was recorded on 08/11/25.
Levels Of Support And Resistance For VRTX Stock
The 24-hour chart illustrates a support level at 393.03, which if violated will result in even more drops to 389.57. On the upside, there is a resistance level at 398.62. A further resistance level may holdings at 400.76.
How much short interest is there in Vertex Pharmaceuticals, Inc?
A steep rise in short interest was recorded in Vertex Pharmaceuticals, Inc stocks on 2025-08-15, dropping by -0.49 million shares to a total of 3.7 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 4.19 million shares. There was a decline of -13.17%, which implies that there is a negative sentiment for the stock.
